The ZINO Society team has been working very hard over the past few weeks to put together our upcoming ZINO Life Investment Forum which will occur this coming Tuesday, March 8th at the Pan Pacific Hotel in Seattle. I want to recognize them with a big THANK YOU for all their efforts to produce what I know will be a fascinating and productive angel investment forum!
Kristie Lanum, our Chief Dealflow Officer, has done a masterful job of recruiting, screening, scheduling coaching and preparing 13 ZINOpreneurs to share 7 minute pitches describing their companies during the afternoon event plus a traction update from our ZZIF 2007 Fund Winner, Healionics. Please see the full list of presenting entrepreneurs at the end of this blog posting.
Mary Holmes, our Chief Marketing Officer, has put together a fascinating, expert panel including John Bowers of SonoSite, Tom Clement of Pathway Medical Technologies, Chris Rivera of WBBA, Dave Schubert of Accelerator Corporation, and Alan Smith of Fenwick & West who will share their perspectives on the life sciences business sector and also ask the selected ZINO Life 2011 Fund Finalists follow-up Due Diligence LIVE! questions at the end of the afternoon.
ZINO Life attendees will choose the “best investment opportunity” and the “best presenter” ZINO Zenith Awards which will be awarded at the end of the business session. The ZINO Annual Angel Investment Forums Fund investors will select four “best investment opportunity” finalists whom the investors will enter into due diligence following the forum.
Robin Moore, Events and Marketing Director, has handled hundreds of details including all the communication to attendees, reservations and event organization. If you are interested in attending, you can click HERE to make reservations.
Here is the full list of ZINO Life 2011 ZINOpreneur presenting companies:
Aspetica, Inc. / David Hatton
Aseptica’s technology prevents catheter related infections. We save tens of thousands of lives and hundreds of millions of dollars every year.
Cerevast Therapeutics, Inc. / Kendall SteverCerevast Therapeutics, Inc. is a medical technology company focused on the development of SonoLysis for the treatment of acute ischemic stroke.
Del Mar Pharmaceuticals / Jeffrey Bacha
Del Mar is developing proven drug candidates that have previously demonstrated human clinical activity in orphan and large-market cancer indications.
DNA Guide, Inc. / Bill KimmerlyDNA Guide develops software to navigate the personal genome for use by pathologists, genetic counselors, health care professionals, and patients.
Emergent Detection / Eric Fogel
Emergent Detection’s BodyKey helps people lose weight more effectively by providing personalized, daily feedback about their body through a simple biochemical test.
Empowering Engineering Technologies / Brian Glaister EETech’s ExoWalk products help people with wheelchairs walk their way to better qualities of life.
FiatLux Imaging, Inc. / Max Lyon FiatLux provides a secure online service for the transport, viewing, sharing and storage of, medical images by medical professionals and patients.
GenQual Corp. / Jonathan Mirich
GenQual designs molecular diagnostics to facilitate early disease detection, diagnosis, and treatment approaches.
Impel NeuroPharma / Michael Hite
Impel is developing a novel drug delivery device to enable central nervous system drugs to bypass the blood-brain barrier.
Network Immunology Inc. / George Hoffman
Network Immunology has made discoveries expected to significantly advance the fields of both vaccination and organ transplantation.
Sinuwave Technologies Corp. / Jim BalcomSinuwave is adapting an already proven, high gross margin, disposable drug-device combination technology for the treatment of chronic sinusitis (CS).
S-Ray Incorporated / Steve Baird S-Ray owns a unique way of using ultrasound to detect cracks and cavities in teeth, without radiation.
VacuPractor / Paul Hagen VacuPractor is a revolutionary new treatment device for lower back pain. It is patented and registered with the FDA.